The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although several electrospray ionization-MS and NMR studies have examined GTA and GTB interactions with their respective donors in the presence of Mn 2ϩ (33-35), it remains difficult to understand the influence of substrate binding on conformational changes in the absence of fully liganded structures.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The structural basis for specificity in human ABO(H) blood group biosynthesis
Patenaude, S. I., Seto, N. O. L., Borisova, S. N., Szpacenko, A., Marcus, S. L., Palcic, M. M., & Evans, S. V. (2002) · Nature Structural Biology · doi:10.1038/nsb832 · Cited by 273
Self-citationAlfaro, J. A., Zheng, R. B., Persson, M., Letts, J. A., Polakowski, R., Bai, Y., Borisova, S. N., Seto, N. O. L., Lowary, T. L., Palcic, M. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708669200 · Cited by 96
Self-citation
Research works printed but not linked: 37
- Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E. (eds.): Essentials of glycobiology. Cold Spring Harbor Laboratory, New York (2009)
- Brown, J.R., Fuster, M.M., Li, R., Varki, N., Glass, C.A., Esko, J.D.: A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin. Cancer Res. 12, 2894–2901 (2006) · DOI
- Kannagi, R.: Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj. J. 20, 353–364 (2004) · DOI
- Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., Kimura, N.: Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 95, 377–384 (2004) · DOI · Paper page
- Mathew, B., Schmidt, R.R.: Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings. Carbohydr. Res. 342, 558–566 (2007) · doi:10.1016/j.carres.2006.08.016
- Palcic, M.M., Heerze, L.D., Srivastava, O.P., Hindsgaul, O.: A bisubstrate analog inhibitor for alpha(1–2)-fucosyltransferase. J. Biol. Chem. 264, 17174–17181 (1989) · DOI
- Jung, K.H., Schmidt, R.R.: Glycosyltransferase inhibitors. In: Wong, C.-H. (ed.) Carbohydrate-based drug discovery, pp. 609–659. Wiley-VCH, Weinheim (2003) · doi:10.1002/3527602437.ch23
- Hamilton, S.R., Gerngross, T.U.: Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr. Opin. Biotechnol. 18, 387–392 (2007) · DOI · Paper page
- Muller, B., Schaub, C., Schmidt, R.R.: Efficient sialyltransferase inhibitors based on transition-state analogues of the sialyl donor. Angew. Chem. Int. Edit. 37, 2893–2897 (1998) · DOI
- Schaub, C., Muller, B., Schmidt, R.R.: New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay. Glycoconj. J. 15, 345–354 (1998) · DOI
- Skropeta, D., Schworer, R., Haag, T., Schmidt, R.R.: Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues. Glycoconj. J. 21, 205–219 (2004) · doi:10.1023/b:glyc.0000045093.96413.62
- Izumi, M., Yuasa, H., Hashimoto, H.: Bisubstrate analogues as glycosyltransferase inhibitors. Curr. Top Med. Chem. 9, 87–105 (2009) · doi:10.2174/156802609787354351
- Izumi, M., Kaneko, S., Yuasa, H., Hashimoto, H.: Synthesis of bisubstrate analogues targeting alpha-1, 3-fucosyltransferase and their activities. Org. Biomol. Chem. 4, 681–690 (2006) · doi:10.1039/b513897c
- Yazer, M.H., Olsson, M.L., Palcic, M.M.: The cis-AB blood group phenotype: fundamental lessons in glycobiology. Transfus. Med. Rev. 20, 207–217 (2006) · DOI
- Mayer, M., Meyer, B.: Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38, 1784–1788 (1999) · DOI · Paper page
- Scherf, T., Anglister, J.: A T1 rho-filtered two-dimensional transferred NOE spectrum for studying antibody interactions with peptide antigens. Biophys. J. 64, 754–761 (1993) · doi:10.1016/s0006-3495(93)81436-x
- Jahnke, W., Rudisser, S., Zurini, M.: Spin label enhanced NMR screening. J. Am. Chem. Soc. 123, 3149–3150 (2001) · DOI
- Meyer, B., Peters, T.: NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew. Chem. Int. Ed. Engl. 42, 864–890 (2003) · DOI · Paper page
- Ludwig, C., Guenther, U.L.: Ligand based NMR methods for drug discovery. Front. Biosci. 14, 4565–4574 (2009) · DOI
- Diercks, T., Coles, M., Kessler, H.: Applications of NMR in drug discovery. Curr. Opin. Chem. Biol. 5, 285–291 (2001) · DOI
- Coles, M., Heller, M., Kessler, H.: NMR-based screening technologies. Drug. Discov. Today 8, 803–810 (2003) · doi:10.1016/s1359-6446(03)02796-x
- Pellecchia, M., Bertini, I., Cowburn, D., Dalvit, C., Giralt, E., Jahnke, W., James, T.L., Homans, S.W., Kessler, H., Luchinat, C., Meyer, B., Oschkinat, H., Peng, J., Schwalbe, H., Siegal, G.: Perspectives on NMR in drug discovery: a technique comes of age. Nat. Rev. Drug Discov. 7, 738–745 (2008) · DOI · Paper page
- Wyss, D.F., McCoy, M.A., Senior, M.M.: NMR-based approaches for lead discovery. Curr. Opin. Drug Discov. Devel. 5, 630–647 (2002)
- Marcus, S.L., Polakowski, R., Seto, N.O., Leinala, E., Borisova, S., Blancher, A., Roubinet, F., Evans, S.V., Palcic, M.M.: A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase. J. Biol. Chem. 278, 12403–12405 (2003) · DOI · Paper page
- Hwang, T.L., Shaka, A.J.: Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112, 275–279 (1995) · DOI · Paper page
- Sindhuwinata, N., Miunoz, E., Munoz, F.J., Palcic, M.M., Peters, H., Peters, T.: Binding of an acceptor substrate analog enhances the enzymatic activity of human blood group B galactosyltransferase. Glycobiology. in press. · DOI · Paper page
- Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J.: AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. (2009) · DOI · Paper page
- Blume, A., Angulo, J., Biet, T., Peters, H., Benie, A.J., Palcic, M., Peters, T.: Fragment-based screening of the donor substrate specificity of human blood group B galactosyltransferase using saturation transfer difference NMR. J. Biol. Chem. 281, 32728–32740 (2006) · DOI · Paper page
- Shoemaker, G.K., Soya, N., Palcic, M.M., Klassen, J.S.: Temperature-dependent cooperativity in donor-acceptor substrate binding to the human blood group glycosyltransferases. Glycobiology 18, 587–592 (2008) · DOI
- Stockman, B.J., Dalvit, C.: NMR screening techniques in drug discovery and drug design. Prog. Nucl. Magn. Reson. Spectrosc. 41, 187–231 (2002) · DOI · Paper page
- Dalvit, C., Flocco, M., Knapp, S., Mostardini, M., Perego, R., Stockman, B.J., Veronesi, M., Varasi, M.: High-throughput NMR-based screening with competition binding experiments. J. Am. Chem. Soc. 124, 7702–7709 (2002) · DOI
- Manzenrieder, F., Frank, A.O., Kessler, H.: Phosphorus NMR spectroscopy as a versatile tool for compound library screening. Angew. Chem. Int. Ed. Engl. 47, 2608–2611 (2008) · DOI
- Klages, J., Coles, M., Kessler, H.: NMR-based screening: a powerful tool in fragment-based drug discovery. Analyst 132, 693–705 (2007) · DOI
- Leone, M., Freeze, H.H., Chan, C.S., Pellecchia, M.: The Nuclear overhauser effect in the lead identification process. Curr. Drug. Discov. Technol. 3, 91–100 (2006) · doi:10.2174/157016306778108884
- Sem, D.S., Pellecchia, M.: NMR in the acceleration of drug discovery. Curr. Opin. Drug Discov. Devel. 4, 479–492 (2001)
- Schuffenhauer, A., Ruedisser, S., Marzinzik, A.L., Jahnke, W., Blommers, M., Selzer, P., Jacoby, E.: Library design for fragment based screening. Curr. Top Med. Chem. 5, 751–762 (2005) · DOI · Paper page
- Rudisser, S., Jahnke, W.: NMR and in silico screening. Comb. Chem. High Throughput Screen 5, 591–603 (2002) · doi:10.2174/1386207023329987
Cited by
Gagnon, S. M. L., Meloncelli, P. J., Zheng, R. B., Haji-Ghassemi, O., Johal, A. R., Borisova, S. N., Lowary, T. L., & Evans, S. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.682401 · Cited by 17
Metadata
- Authors
- Rademacher, C., Landström, J., Sindhuwinata, N., Palcic, M. M., Widmalm, G., & Peters, T.
- Venue
- Glycoconjugate Journal
- Published
- 2010-03-09
- Volume
- 27
- Issue
- 3
- Pages
- 349-358
- ISSN
- 0282-0080
- 1573-4986
- Cited by
- 17
- References
- 2
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments. https://app.cochat.ai/papers/10.1007/s10719-010-9282-5
- The paper
- Rademacher, C., Landström, J., Sindhuwinata, N., Palcic, M. M., Widmalm, G., & Peters, T. (2010). NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments. Glycoconjugate Journal. https://doi.org/10.1007/s10719-010-9282-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.